IMAGE

Fig 1

ID
ZDB-IMAGE-210327-21
Source
Figures for Huang et al., 2021
Image
Figure Caption

Fig 1 Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival.

After treating Hep3B, Mahlavu, and HepJ5 cells with different doses of MG (0~40 μg/ml) for 48h, the relative cell survival rate was determined using an SRB assay. Survival of vehicle-treated cells was defined as 100%. MG treatment showed reduction of the cell survival rate in HCC cells in a dose-dependent manner. Data are expressed as the mean±SD of three independent experiments in triplicate (* p<0.05, ** p<0.01).

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS One